Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)
Public ClinicalTrials.gov record NCT04978818. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children
Study identification
- NCT ID
- NCT04978818
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Other
- Enrollment
- 333 participants
Conditions and interventions
Conditions
Interventions
- Vaxelis Drug
- PedvaxHIB Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Weeks to 12 Weeks
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 26, 2022
- Primary completion
- Oct 25, 2023
- Completion
- Oct 25, 2023
- Last update posted
- Jun 23, 2024
2022 – 2023
United States locations
- U.S. sites
- 5
- U.S. states
- 3
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Native Medical Center | Anchorage | Alaska | 99508 | — |
| Chinle Center for Indigenous Health | Chinle | Arizona | 86503 | — |
| Fort Defiance Center for Indigenous Health | Fort Defiance | Arizona | 86504 | — |
| Gallup Center for Indigenous Health | Gallup | New Mexico | 87301 | — |
| Shiprock Center for Indigenous Health | Shiprock | New Mexico | 87420 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04978818, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2024 · Synced Jul 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04978818 live on ClinicalTrials.gov.